FY18 Guide & Annual Results, page-9

I expect BAL to release very strong annual results for the 2018 financial year.
Majority revenue is still coming from Australian market.
Recent Vaccine Scandal in China, just does not help Chinese mums buying infant formula in China, would drive them to buy infant formula direct from overseas, imo.

A2 infant formula revenue increase was mainly coming from Australian & New Zealand's markets, as China & other Asia's markets revenue was increased from $114m to $119m.